Skip to main content
. 2022 Mar 7;20(5):1193–1205. doi: 10.1111/jth.15673

FIGURE 2.

FIGURE 2

First and total arterial and venous thrombotic events, per 100 patient‐years. The first and total arterial and venous thrombotic events per 100 patient years in the Placebo and Rivaroxaban groups, respectively, are provided. ARR, absolute risk reduction; CI, confidence interval; HR, hazard ratio; p, p‐value; p‐y, patient‐yearsNote: arterial and venous events include acute limb ischemia, major amputation of vascular cause, MI, ischemic stroke, and symptomatic VTE (deep vein thrombsis and pulmonary embolism).